Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000540391 | SCV000637247 | pathogenic | Congenital dyserythropoietic anemia, type II | 2017-08-17 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys193*) in the SEC23B gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SEC23B-related disease. Loss-of-function variants in SEC23B are known to be pathogenic (PMID: 19561605, 25044164). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV003766993 | SCV004582959 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2017-07-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys193*) in the SEC23B gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SEC23B-related disease. Loss-of-function variants in SEC23B are known to be pathogenic (PMID: 19561605, 25044164). For these reasons, this variant has been classified as Pathogenic. |